Paper8302763
Dose proportionality and population characteristics of oral fadrozole hydrochloride, an aromatase inhibitor, in postmenopausal women.
Kochak GM and 2 others. Pharm Res, 1993. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Dose proportionality and population characteristics of oral fadrozole hydrochloride, an aromatase inhibitor, in postmenopausal women. Papers, record 8302763. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8302763
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dose proportionality and population characteristics of oral fadrozole hydrochloride, an aromatase inhibitor, in postmenopausal women.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aromatase Inhibitors | Major topic |
| Fadrozole | Major topic |
| Adult | |
| Aged | |
| Aging | |
| Body Height | |
| Body Weight | |
| Female | |
| Humans | |
| Middle Aged | |
| Prospective Studies |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1356733 | Effects of low-density lipoprotein and ethinyl estradiol on cyclosporine metabolism in isolated rat liver perfusions. | Drug Metab Dispos | 1992 | https://conductscience.org/library/papers/1356733 | PubMed |
| 2 | 2150591 | CGS 16949A, a new aromatase inhibitor in the treatment of breast cancer--a phase I study. | Ann Oncol | 1990 | https://conductscience.org/library/papers/2150591 | PubMed |
| 3 | 2146284 | The pharmacodynamic inhibition of estrogen synthesis by fadrozole, an aromatase inhibitor, and its pharmacokinetic disposition. | J Clin Endocrinol Metab | 1990 | https://conductscience.org/library/papers/2146284 | PubMed |
| 4 | 925482 | Effects of ethinyl estradiol on hepatic microsomal proteins and the turnover of cytochrome P-450. | J Lab Clin Med | 1977 | https://conductscience.org/library/papers/925482 | PubMed |
| 5 | 901418 | Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol. | Biochem J | 1977 | https://conductscience.org/library/papers/901418 | PubMed |
| 6 | 2521224 | Inhibition of aromatase with CGS 16949A in postmenopausal women. | J Clin Endocrinol Metab | 1989 | https://conductscience.org/library/papers/2521224 | PubMed |
| 7 | 2137721 | A phase I trial of CGS 16949A. A new aromatase inhibitor. | Cancer | 1990 | https://conductscience.org/library/papers/2137721 | PubMed |
| 8 | 3456482 | Androgen and estrogen metabolism: relationship to obesity. | Metabolism | 1986 | https://conductscience.org/library/papers/3456482 | PubMed |
| 9 | 3285175 | Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450. | Mol Pharmacol | 1988 | https://conductscience.org/library/papers/3285175 | PubMed |
| 10 | 629289 | Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. | Am J Obstet Gynecol | 1978 | https://conductscience.org/library/papers/629289 | PubMed |
| 11 | 2748520 | Intra- and intersubject variability: mixed-effects statistical analysis of repeated doses of an angiotensin converting enzyme inhibitor, CGS 16617. | Pharm Res | 1989 | https://conductscience.org/library/papers/2748520 | PubMed |
| 12 | 1535443 | Population characteristics of biological systems influenced by multicomponent random and uniform variation. | Pharm Res | 1992 | https://conductscience.org/library/papers/1535443 | PubMed |
| 13 | 8298071 | The effect of food on the relative bioavailability of fadrozole hydrochloride. | Biopharm Drug Dispos | 1993 | https://conductscience.org/library/papers/8298071 | PubMed |
| 14 | 1133154 | Production of estrone and fractional conversion of circulating androstenedione to estrone in women with endometrial carcinoma. | J Clin Endocrinol Metab | 1975 | https://conductscience.org/library/papers/1133154 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 15568891 | Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy. | Clin Pharmacokinet | 2004 | https://conductscience.org/library/papers/15568891 | PubMed |
| 12844324 | Clinical pharmacokinetics of aromatase inhibitors and inactivators. | Clin Pharmacokinet | 2003 | https://conductscience.org/library/papers/12844324 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CYP19A1 | 1588 | PubTator's text mining | https://conductscience.org/library/genes/1588 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8302763
GET https://conductscience.org/api/papers/v1/8302763/authors